New corporate strategy bears first fruit

HONG KONG and AMSTERDAM – Leader Biomedical, the parent company of EMCM and affiliate of aap Joints, continues to deliver on its corporate strategy through the establishment of new subsidiaries and global partnerships. In line with its strategy, the company has furthermore unveiled its own corporate identity and website.

The new corporate identity centres on the idea of “Extending your Reach” by increasing the access of next generation healthcare solutions to global markets, with an emphasis on emerging markets. Since the announcement of its strategy in 2014, the company has already started to deliver on this promise by setting up subsidiaries in India and China and consolidating its marketing and sales operations in Amsterdam, the Netherlands. Finally, it has also entered into a partnership with Dora Medikal to promote its proprietary _eCOO^®Technology in Turkey.

“Leader Biomedical was established to be a leading provider of biomaterials and medical implants with a strong footprint in high-growth markets, like China,” said Prof. Lugee Li, Founder and sole shareholder of Leader Biomedical.

“Through hard work and dedication, we’ve been able to move quickly and I am very pleased with the progress we have made. This is however only the beginning and you can expect more exciting news in the near future,” he continues.

Ultimately, Leader Biomedical’s ambition is to develop an integrated value chain encompassing new technological innovations, Manufacturing Operations (CMO & OEM) and product marketing.

Leader Biomedical was founded by Prof. Li following the acquisitions of EMCM and aap Joints. The new corporate identity will bring these subsidiaries – along with future acquisitions – together under a single umbrella, uniting them through a common mission and vision.

For business queries, please click here.

For media, please click here.